查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1987984

Buprofezin市场：2026-2032年全球市场预测（按剂型、作物、应用方法、最终用户和销售管道）

Buprofezin Market by Formulation Type, Crop Type, Application Method, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，Buprofezin市值为 8.0181 亿美元，预计到 2026 年将成长至 8.4945 亿美元，复合年增长率为 5.87%，到 2032 年将达到 11.9547 亿美元。

主要市场统计数据
基准年 2025 8.0181亿美元
预计年份：2026年 8.4945亿美元
预测年份 2032 1,195,470,000 美元
复合年增长率 (%) 5.87%

权威介绍Buprofezin：作为昆虫生长调节剂的作用机制、在主要作物中的应用、监管和管理背景。

在现代综合虫害管理（IPM）体系中，Buprofezin作为一种昆虫生长调节剂，占据着独特的地位。它能抑制主要吸汁害虫的蜕皮和发育。农民依靠其标靶作用机制来控製粉蝨、介壳虫、叶蝉和其他半翅目害虫的族群数量，这些害虫威胁棉花、水稻、蔬菜和某些水果的生长。由于Buprofezin作用于幼虫阶段而非立即击倒害虫，因此在抗药性控制和残留因素是战术性时，它可以与化学和生物防治剂有效联合使用。

技术、监管和分销方面的变化正在重新定义Buprofezin产品的配方、监管和在作物系统中的部署方式。

随着多项变革性趋势的交汇，Buprofezin的应用格局正在发生变化，农作物保护产品的研发、行销和使用方式也随之重塑。精密农业和数位化决策工具改变了施用时间和剂量选择，使种植者能够根据即时病虫害监测结果，将Buprofezin纳入针对性防治措施。同时，製剂科学也在不断发展，以确保其与混合伙伴的兼容性，提高附着力、耐雨性和作物安全性，进而影响该产品在不同种植系统中的应用。

2025 年的关税环境如何对供应链、采购和分销产生连锁反应，从而重塑Buprofezin製剂和原料的取得模式。

美国2025年实施的关税和贸易措施对Buprofezin等产品产生了连锁的间接影响，这些产品依赖全球供应链获取活性成分、惰性成分和製剂服务。某些前驱化学品和包装材料的进口成本上升，增加了从国际采购原料的製剂生产商的单位成本，迫使采购团队重新评估其供应商组合，优先考虑在地采购和供应关係多元化。因此，一些生产商调整了生产顺序和库存策略，以降低关税变化带来的风险，并确保在关键种植季节的供应连续性。

详细的细分洞察揭示了配方选择、作物类型、应用方法、最终用户概况和销售管道如何共同影响采用Buprofezin的决策。

透过对关键细分维度的深入分析，我们揭示了Buprofezin产品的不同需求驱动因素、应用偏好和商业化策略。相关人员会根据製剂类型评估乳化剂、颗粒剂、悬浮剂和可湿性粉剂在特定施用时间、作物安全性以及操作人员要求方面的适用性。当需要快速混合和与界面活性剂相容时，乳化剂通常是首选；而颗粒剂则可透过土壤和水在稻田和广​​域施用中实现高度精准的施用。在需要确保叶面接触和在复杂作物冠层上均匀覆盖才能达到最佳效果的情况下，悬浮剂和可湿性粉剂仍然非常实用。

美洲、欧洲、中东和非洲以及亚太地区在农业、法规和分销方面的细微区域差异决定了产品的使用和商业化路径。

区域趋势影响着Buprofezin在不同种植系统中的应用、监管和商业化方式。在美洲，噻嗪酮的应用模式反映了特殊作物和农作物需求的混合。技术支援和经销商网路在将标籤限制转化为田间实践方面发挥核心作用，种植者通常寻求将噻嗪酮与适用于棉花、蔬菜和水果作物系统的更广泛的病虫害防治工具相结合。该地区的监管合作和管理计划优先考虑工人安全和环境风险降低，从而影响製剂的选择和施用时间。

企业层面的策略挑战主要集中在配方创新、监管合规、销售管道合作和服务整合等方面，以保持竞争优势。

製造商、製剂製造商和服务供应商之间的竞争格局主要围绕着製剂创新、法规专业知识和销售管道覆盖范围。主要企业优先投资于製剂平台，以增强与精准喷洒技术的兼容性，保持对目标复杂害虫的有效性，并降低工人接触风险。同时，契约製造和自有品牌协议为区域性製剂製造商创造了机会，使其能够根据当地作物系统和法规条件客製化产品，从而提高其市场准入的灵活性。

针对製造商和经销商的具体建议，以加强供应韧性、促进管理并优化Buprofezin产品的商业化。

产业领导企业可以采取多项切实可行的措施来增强产品的稳定性、维持药效并扩大Buprofezin的合理使用范围。首先，应优先研发更易于使用、减少工人接触并增强与综合虫害管理 (IPM) 实践相容性的配方。投资于助剂科学和喷洒系统可以降低推广门槛，并延长产品在其整个生命週期中的效用。其次，应建立健全的管理和抗药性管理计划，包括清晰的标籤说明、针对经销商和顾问的培训倡议，以及有助于作物轮作和混配选择的监测通讯协定。

采用高度透明的混合调查方法，结合一手访谈、监管和技术文献综述以及实地检验，全面检验Buprofezin的实际应用。

本研究采用混合调查方法，结合一手访谈、监管文件审查、技术文献整合和实地检验，以确保获得稳健且多角度的研究结果。一手定性访谈对象包括作物保护专家、製剂科学家、註册监管官员、经销商和种植者顾问，旨在了解田间实践和策略重点。补充的二手分析则利用同行评审的昆虫学和农业化学品文献、公开的监管文件以及公司资讯披露，来阐明药效概况、残留控制措施和标籤限制等问题。

总之，综合分析强调了管理、供应弹性和协调的商业策略的必要性，以及Buprofezin作为永续农业化学品的角色。

总之，Buprofezin仍是综合虫害管理方案中防治棉花、稻米、蔬菜和某些水果作物中特定吸汁害虫的有效工具。儘管监管和贸易环境对供应的持续性和成本结构构成挑战，但製剂技术的进步和数据驱动的应用实践进一步增强了噻嗪酮的作用。来自各方的压力，例如对产品管理的期望、通路的变化以及贸易政策的转变，都要求我们在采购、产品开发以及与生产商的合作方面采取适应性措施。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章Buprofezin市场按剂型划分

  • 乳化浓缩液
  • 颗粒
  • 用于悬浮液的悬浮液溶液
  • 可湿性粉

第九章Buprofezin市场：依作物类型划分

  • 棉布
  • 水果
    • 莓果
    • 柑橘
    • 核果
  • 米
  • 蔬菜
    • 水果和蔬菜
    • 绿叶蔬菜
    • 根茎类

第十章：按应用方法分類的Buprofezin市场

  • 叶面喷布
  • 种子处理
  • 土壤处理

第十一章Buprofezin市场：依最终用户划分

  • 大型农场
  • 小规模农场

第十二章Buprofezin市场：依销售管道划分

  • 直销
  • 销售代理
  • 在线的

第十三章Buprofezin市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章Buprofezin市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章Buprofezin市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国Buprofezin市场

第十七章：中国Buprofezin市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Adama Agricultural Solutions Ltd.
  • Albaugh LLC
  • Anmol Biotech Private Limited
  • Aristo Bio-tech And Lifescience Limited
  • Bayer AG
  • Bharat Group
  • Biostadt India Limited
  • Canary Agro Chemicals Private Limited
  • Croda International PLC
  • Dhanuka Agritech Limited
  • Gharda Chemicals Limited
  • Hebei Enge Biotech Co., Ltd.
  • Insecticides（India）Limited
  • Jaffer Group
  • Jaivik Crop Care LLP
  • Jiangsu Changqing Agrochemical Co., Ltd.
  • Kenvos AG
  • King Quenson Group
  • Merck KGaA
  • Nihon Nohyaku Co., Ltd.
  • Nippon Soda Co., Ltd.
  • Nova Agritech Limited
  • Nufarm Limited
  • Paras Crops Limited
  • Parijat Industries India Pvt. Ltd.
  • Rallis India Limited by Tata Chemicals Limited
  • Shandong United Pesticide Industry Co., Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • UPL Limited
Product Code: MRR-2B4B2861EC8B

The Buprofezin Market was valued at USD 801.81 million in 2025 and is projected to grow to USD 849.45 million in 2026, with a CAGR of 5.87%, reaching USD 1,195.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 801.81 million
Estimated Year [2026] USD 849.45 million
Forecast Year [2032] USD 1,195.47 million
CAGR (%) 5.87%

An authoritative introduction to buprofezin covering its insect growth regulator mode of action, primary crop applications, regulatory and stewardship context

Buprofezin occupies a distinct position within contemporary integrated pest management frameworks as an insect growth regulator that disrupts molting and development in key sap-sucking pests. Agricultural practitioners rely on its targeted mode of action to manage populations of whiteflies, scale insects, planthoppers, and other hemipteran pests that threaten cotton, rice, vegetables, and certain fruit categories. Because it affects immature stages rather than providing acute knockdown, buprofezin integrates effectively with complementary chemistries and biological agents when resistance mitigation and residue considerations shape tactical decisions.

Regulatory scrutiny and stewardship commitments increasingly influence the way formulators and applicators deploy buprofezin. Consequently, formulators have invested in delivery formats that optimize crop safety and operator handling while minimizing non-target exposure. In parallel, growers and advisors have adapted application timing and tank-mix strategies to preserve product efficacy across successive pest generations. Transitioning from single-season interventions toward season-long pest management programs, stakeholders emphasize rotation, monitoring, and compatibility with beneficial insect populations.

Taken together, these dynamics frame the current discourse around buprofezin: it is a strategic tool for controlling specific pest complexes, yet its long-term utility depends on coordinated stewardship, formulation innovation, and alignment with evolving regulatory expectations. Those factors shape procurement decisions, extension messaging, and product development roadmaps in practical ways.

Transformative technological, regulatory, and distributional shifts that are redefining how buprofezin products are formulated, regulated, and deployed across crop systems

The landscape for buprofezin is shifting as several transformative trends converge to reshape how crop protection products are developed, marketed, and used. Precision agriculture and digital decision-support tools have changed application timing and dosage selection, enabling growers to integrate buprofezin into targeted interventions informed by real-time pest monitoring. At the same time, formulation science has evolved to address compatibility with tank-mix partners and to improve adherence, rainfastness, and crop safety, which in turn influences product uptake across diverse cropping systems.

Regulatory tightening and heightened scrutiny on environmental and operator safety have accelerated demand for robust stewardship programs and transparent data packages. Consequently, manufacturers and registrants place greater emphasis on residue characterization, non-target risk assessments, and label clarity. Supply chain dynamics have also changed, as global sourcing and raw material availability prompt formulators to re-evaluate manufacturing footprints and contract partnerships. In addition, shifts in distribution behavior - including expanding direct-to-grower engagement and the growth of online procurement channels - are altering how technical support and training are delivered.

These forces operate together: innovation in formulation and data-driven application practices supports compliance and efficacy, while evolving distribution and supply arrangements change how information and product reach end users. Stakeholders who anticipate and respond to these shifts can protect efficacy, reduce regulatory friction, and capture operational efficiencies that strengthen long-term product viability.

How the 2025 tariff environment produced cascading supply chain, procurement, and distribution effects that reshaped access to buprofezin formulations and inputs

The implementation of tariffs and trade measures by the United States in 2025 created a cascade of indirect effects for products like buprofezin that rely on global supply chains for active ingredients, inert components, and formulation services. Increased import costs for certain precursor chemicals and packaging materials raised the unit cost base for formulators who sourced components internationally, prompting procurement teams to reevaluate supplier portfolios and to prioritize localized or diversified supply relationships. In turn, some manufacturers adjusted production sequencing and inventory policies to mitigate exposure to tariff volatility and to preserve continuity of supply for key cropping periods.

At the distribution and end-user level, cost pass-through dynamics varied by channel and customer type. Large agricultural operations with integrated purchasing and longer-term procurement contracts absorbed short-term input price movements more easily than small-scale farms that depend on spot purchases and may face tighter working capital constraints. Moreover, tariff-driven changes fostered reconfiguration in trade flows, encouraging some suppliers to seek alternative export destinations or to accelerate domestic registration and production plans in tariff-affected markets.

Importantly, the policy environment stimulated closer collaboration between registrants, compliance specialists, and commercial teams to ensure uninterrupted access to labeled products while remaining compliant with regulatory obligations. In sum, tariff developments in 2025 heightened focus on supply chain resilience, supplier diversification, and contractual strategies that buffer growers and formulators from episodic trade disruptions.

Granular segmentation insights revealing how formulation choices, crop categories, application methods, end-user profiles, and sales channels collectively shape buprofezin deployment decisions

Insights across key segmentation dimensions reveal differentiated demand drivers, application preferences, and commercialization strategies for buprofezin products. Based on formulation type, stakeholders evaluate emulsifiable concentrates, granules, suspension concentrates, and wettable powders for their fit with specific application windows, crop safety profiles, and operator handling requirements; emulsifiable concentrates often appeal where rapid mixing and compatibility with surfactants matter, while granule formats can offer targeted soil- or water-delivered options for paddy or broadcast applications. Suspension concentrates and wettable powders remain valuable where foliar contact and uniform coverage across complex canopies determine efficacy.

Based on crop type, users tailor selection to the pest complex and crop physiology. Cotton, fruit, paddy, and vegetables each present unique considerations: cotton programs prioritize control of sap-sucking pests across multiple growth stages; fruit applications require attention to preharvest intervals and pollinator exposure, with fruit categories further dissected across berry, citrus, and stone fruit for varying residue and canopy management needs; paddy systems often favor formulations and application windows synchronized with planthopper life cycles; vegetables require agile application timing across fruit vegetables, leafy vegetables, and root vegetables where harvest schedules and residue tolerances differ.

Based on application method, deployment choices cluster around foliar spray, seed treatment, and soil treatment options, with foliar spray remaining the prevalent mode for rapid suppression of active infestations and seed or soil treatments offering prophylactic protection in select systems. Based on end user, the distinction between large scale farms and small scale farms affects purchasing patterns, technical support needs, and willingness to adopt premium formulations or subscription-based supply models. Based on sales channel, direct sales, distributors, and online platforms each present trade-offs between hands-on technical service, reach into fragmented geographies, and convenience; distributors often provide localized agronomic support while direct sales can bundle technical training and stewardship commitments, and online channels increasingly serve smaller buyers seeking transactional convenience. Together, these segmentation lenses inform product development priorities, extension strategies, and channel investments in ways that reflect agronomic realities and commercial constraints.

Regional agronomic, regulatory, and distribution nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine product use and commercialization pathways

Regional dynamics shape how buprofezin is used, regulated, and commercialized across diverse cropping systems. In the Americas, adoption patterns reflect a mix of specialty crop and row crop needs; technical support and distributor networks play a central role in translating label constraints into field practice, and growers often seek integration with broader pest management tools suitable for cotton, vegetables, and fruit systems. Regulatory engagement and stewardship programs in this region emphasize worker safety and environmental risk mitigation, which influence formulation preferences and application timing.

In Europe, Middle East & Africa, regulatory frameworks and regional climatic diversity create heterogeneous demand and approval conditions. Some jurisdictions emphasize stringent residue and non-target species assessments that shape label language and permissible use patterns, while others prioritize access for key staple or export-oriented crops. Technical advisories and extension networks in these geographies frequently guide growers toward integrated approaches that balance efficacy with compliance and market access objectives.

In Asia-Pacific, agricultural systems characterized by intensive rice cultivation, extensive vegetable production, and significant smallholder presence rely heavily on targeted tools for planthopper and sap-sucking pest complexes. Here, formulations that suit paddy application regimes and mixed-cropping calendars gain traction, and stewardship messaging that accounts for multiple cropping cycles proves essential. Across regions, supply chain configuration, regulatory drivers, and agronomic practices interact to determine which channels, formulations, and advisory models best support effective and sustainable use.

Strategic company-level imperatives focusing on formulation innovation, regulatory stewardship, channel partnerships, and service integration to sustain competitive advantage

Competitive dynamics among manufacturers, formulators, and service providers center on formulation innovation, regulatory expertise, and channel reach. Leading enterprises prioritize investments in formulation platforms that enhance compatibility with precision application technologies and that reduce operator exposure while maintaining efficacy against target pest complexes. At the same time, contract manufacturing and private-label arrangements allow regional formulators to tailor products to local cropping systems and regulatory conditions, creating opportunities for agile market entrants.

R&D teams and regulatory affairs specialists collaborate to build robust data packages that support label renewal, risk mitigation, and stewardship initiatives. Partnerships between technical teams and commercial units increasingly aim to translate efficacy data into actionable extension materials and training programs for distributors and end users. Additionally, companies that offer integrated services - combining product supply with digital advisory tools, monitoring services, or custom formulations - differentiate on the basis of convenience and technical value.

Mergers, licensing arrangements, and distribution partnerships remain important mechanisms for scaling geographic reach and accelerating product registration timelines without duplicative capital investment. In this environment, firms that maintain strong relationships with growers, extension agents, and channel partners can more effectively deploy stewardship programs and respond to evolving regulatory expectations, thereby preserving product relevance over multiple cropping cycles.

Actionable recommendations for manufacturers and distributors to fortify supply resilience, advance stewardship, and optimize commercialization of buprofezin products

Industry leaders can take several practical steps to strengthen product resilience, protect efficacy, and expand responsible use of buprofezin. First, prioritize formulation development that improves ease of use, reduces operator exposure, and enhances compatibility with integrated pest management practices; investing in adjuvant science and delivery systems reduces barriers to adoption and can lengthen product lifecycle utility. Second, build robust stewardship and resistance management programs that combine clear label instructions, train-the-trainer initiatives for distributors and advisors, and monitoring protocols that inform rotation and tank-mix choices.

Third, diversify supply chains by securing multiple qualified suppliers for key inputs and by assessing local or regional manufacturing options to reduce exposure to trade volatility. Fourth, strengthen relationships with end users through bundled services that include agronomic advisory, digital decision-support tools, and field-level diagnostics; these offerings create recurring engagement and improve proper product use. Fifth, engage proactively with regulatory authorities and industry associations to streamline data submissions, address non-target risk considerations, and align residue management strategies with export market requirements.

Finally, tailor commercialization strategies to channel dynamics: support distributors with localized technical materials, develop direct-sales pilots for high-value customers, and design online offerings for smaller buyers who value convenience. By combining technical innovation with supply resilience and targeted commercial models, industry leaders can sustain product relevance while meeting evolving regulatory and grower expectations.

A transparent hybrid research methodology combining primary interviews, regulatory and technical literature review, and field validation to triangulate practical insights on buprofezin use

This research synthesizes insights from a hybrid methodology combining primary interviews, regulatory documentation review, technical literature synthesis, and field-level observation to ensure robust, triangulated findings. Primary qualitative interviews included crop protection specialists, formulation scientists, registrants' regulatory leads, distributors, and grower advisors to capture on-the-ground practices and strategic priorities. Complementary secondary analysis drew on peer-reviewed entomology and agronomy literature, publicly available regulatory filings, and company disclosures to contextualize efficacy profiles, residue management practices, and label constraints.

Field-level observation and practitioner feedback informed assessments of application timing, formulation performance under diverse climatic conditions, and stewardship practices at farm scale. Data triangulation helped reconcile differences between controlled-trial efficacy and practical in-field outcomes, while expert validation workshops reviewed preliminary conclusions to ensure relevance and clarity. Quality assurance measures included cross-referencing regulatory documents against reported use patterns and seeking clarifications from technical interviewees when discrepancies emerged.

Throughout the research process, ethical considerations and confidentiality requirements guided interactions with commercial participants. The methodology emphasizes transparency in source attribution and replicability of approach while acknowledging practical limitations inherent in rapidly evolving regulatory and trade contexts.

Concluding synthesis emphasizing the sustained agronomic role of buprofezin alongside the necessity for stewardship, supply resilience, and coordinated commercial strategies

In conclusion, buprofezin remains a targeted and valuable tool within integrated pest management programs for specific sap-sucking pest complexes across cotton, rice, vegetables, and select fruit crops. Its role is reinforced by formulation advancements and data-driven application practices, even as regulatory scrutiny and trade dynamics challenge supply continuity and cost structures. The combined pressures of stewardship expectations, changing distribution channels, and trade policy shifts necessitate adaptive approaches in procurement, product development, and grower engagement.

Stakeholders that align formulation innovation with robust stewardship, diversify supply relationships, and invest in channel-specific technical support will better sustain efficacy and retain grower confidence. Moreover, integrating digital advisory services and localized training into commercialization strategies strengthens correct use and reduces the risk of resistance development. As the sector evolves, decision-makers should prioritize operational resilience and proactive regulatory engagement to preserve both access and product integrity.

Taken together, these conclusions underscore the importance of coordinated action across R&D, regulatory, supply chain, and commercial functions to maintain the utility of buprofezin in modern crop protection portfolios while addressing environmental and market expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Buprofezin Market, by Formulation Type

  • 8.1. Emulsifiable Concentrate
  • 8.2. Granule
  • 8.3. Suspension Concentrate
  • 8.4. Wettable Powder

9. Buprofezin Market, by Crop Type

  • 9.1. Cotton
  • 9.2. Fruit
    • 9.2.1. Berry
    • 9.2.2. Citrus
    • 9.2.3. Stone Fruit
  • 9.3. Paddy
  • 9.4. Vegetables
    • 9.4.1. Fruit Vegetables
    • 9.4.2. Leafy Vegetables
    • 9.4.3. Root Vegetables

10. Buprofezin Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Seed Treatment
  • 10.3. Soil Treatment

11. Buprofezin Market, by End User

  • 11.1. Large Scale Farms
  • 11.2. Small Scale Farms

12. Buprofezin Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Buprofezin Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Buprofezin Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Buprofezin Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Buprofezin Market

17. China Buprofezin Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adama Agricultural Solutions Ltd.
  • 18.6. Albaugh LLC
  • 18.7. Anmol Biotech Private Limited
  • 18.8. Aristo Bio-tech And Lifescience Limited
  • 18.9. Bayer AG
  • 18.10. Bharat Group
  • 18.11. Biostadt India Limited
  • 18.12. Canary Agro Chemicals Private Limited
  • 18.13. Croda International PLC
  • 18.14. Dhanuka Agritech Limited
  • 18.15. Gharda Chemicals Limited
  • 18.16. Hebei Enge Biotech Co., Ltd.
  • 18.17. Insecticides (India) Limited
  • 18.18. Jaffer Group
  • 18.19. Jaivik Crop Care LLP
  • 18.20. Jiangsu Changqing Agrochemical Co., Ltd.
  • 18.21. Kenvos AG
  • 18.22. King Quenson Group
  • 18.23. Merck KGaA
  • 18.24. Nihon Nohyaku Co., Ltd.
  • 18.25. Nippon Soda Co., Ltd.
  • 18.26. Nova Agritech Limited
  • 18.27. Nufarm Limited
  • 18.28. Paras Crops Limited
  • 18.29. Parijat Industries India Pvt. Ltd.
  • 18.30. Rallis India Limited by Tata Chemicals Limited
  • 18.31. Shandong United Pesticide Industry Co., Ltd.
  • 18.32. Sumitomo Chemical Co., Ltd.
  • 18.33. Thermo Fisher Scientific Inc.
  • 18.34. UPL Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BUPROFEZIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BUPROFEZIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 154. GCC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 155. GCC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 178. G7 BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 186. NATO BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)